Global Iodinated Contrast Media (ICM) Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Iodinated Contrast Media (ICM) Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
ICM are drugs containing iodine that are given to patients to enhance the ability to see blood vessels and organs on medical images such as X-rays or computed tomography (CT) scans. These images provide greater detail when necessary to help health care professionals diagnose potential problems.
Iodinated Contrast Media (ICM) report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Iodinated Contrast Media (ICM) market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Medical Imaging and Disease Diagnosis are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Iodinated Contrast Media (ICM) industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Iodinated Contrast Media (ICM) key manufacturers include Bayer, GE Healthcare, Guerbet, Bracco, Fuji Pharma, Jiangsu Hengrui Medicine, Starry Pharmaceutical, Beilu Pharmaceutical and Yangzijiang Pharmaceutical Industry, etc. Bayer, GE Healthcare, Guerbet are top 3 players and held % sales share in total in 2022.
Iodinated Contrast Media (ICM) can be divided into Ionic Contrast Media and Non-ionic Contrast Media, etc. Ionic Contrast Media is the mainstream product in the market, accounting for % sales share globally in 2022.
Iodinated Contrast Media (ICM) is widely used in various fields, such as Medical Imaging, Disease Diagnosis and Others,, etc. Medical Imaging provides greatest supports to the Iodinated Contrast Media (ICM) industry development. In 2022, global % sales of Iodinated Contrast Media (ICM) went into Medical Imaging filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Iodinated Contrast Media (ICM) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Bayer
GE Healthcare
Guerbet
Bracco
Fuji Pharma
Jiangsu Hengrui Medicine
Starry Pharmaceutical
Beilu Pharmaceutical
Yangzijiang Pharmaceutical Industry
Tyco International
Hexal AG
Sanochemia Pharmazeutika
Agfa Healthcare
Segment by Type
Ionic Contrast Media
Non-ionic Contrast Media
Medical Imaging
Disease Diagnosis
Others
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Iodinated Contrast Media (ICM) market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Iodinated Contrast Media (ICM), product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Iodinated Contrast Media (ICM) industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Iodinated Contrast Media (ICM) in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Iodinated Contrast Media (ICM) introduction, etc. Iodinated Contrast Media (ICM) Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Iodinated Contrast Media (ICM) market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Iodinated Contrast Media (ICM) report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Iodinated Contrast Media (ICM) market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Medical Imaging and Disease Diagnosis are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Iodinated Contrast Media (ICM) industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Iodinated Contrast Media (ICM) key manufacturers include Bayer, GE Healthcare, Guerbet, Bracco, Fuji Pharma, Jiangsu Hengrui Medicine, Starry Pharmaceutical, Beilu Pharmaceutical and Yangzijiang Pharmaceutical Industry, etc. Bayer, GE Healthcare, Guerbet are top 3 players and held % sales share in total in 2022.
Iodinated Contrast Media (ICM) can be divided into Ionic Contrast Media and Non-ionic Contrast Media, etc. Ionic Contrast Media is the mainstream product in the market, accounting for % sales share globally in 2022.
Iodinated Contrast Media (ICM) is widely used in various fields, such as Medical Imaging, Disease Diagnosis and Others,, etc. Medical Imaging provides greatest supports to the Iodinated Contrast Media (ICM) industry development. In 2022, global % sales of Iodinated Contrast Media (ICM) went into Medical Imaging filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Iodinated Contrast Media (ICM) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Bayer
GE Healthcare
Guerbet
Bracco
Fuji Pharma
Jiangsu Hengrui Medicine
Starry Pharmaceutical
Beilu Pharmaceutical
Yangzijiang Pharmaceutical Industry
Tyco International
Hexal AG
Sanochemia Pharmazeutika
Agfa Healthcare
Segment by Type
Ionic Contrast Media
Non-ionic Contrast Media
Segment by Application
Medical Imaging
Disease Diagnosis
Others
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Iodinated Contrast Media (ICM) market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Iodinated Contrast Media (ICM), product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Iodinated Contrast Media (ICM) industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Iodinated Contrast Media (ICM) in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Iodinated Contrast Media (ICM) introduction, etc. Iodinated Contrast Media (ICM) Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Iodinated Contrast Media (ICM) market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices